26-APR-2025 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 733 10 522 77 937 159 968
ERLYTX 73 3 157 12 146 19 116
GI 217 2 104 22 268 34 207
GU 521 10 522 48 584 89 542
LEUK 86 2 104 5 61 15 91
LUNG 577 2 104 12 146 20 122
LYMPH 294 10 522 32 390 73 444
MELAN 434 3 157 31 377 69 420
MMYEL 316 1 52 16 195 29 177
MULT 20 0 0 0 0 0 0
OTHER 46 0 0 1 12 3 18
PREV 8 0 0 0 0 2 12
SXQOL 7 1 52 1 12 1 6
Total 3332 44 2296 257 3128 513 3123

26-APR-2025 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
CCD 520 1 52 5 61 16 97
ERLYTX 5 0 0 0 0 2 12
GU 4 0 0 0 0 0 0
LEUK 434 5 261 36 438 104 633
LUNG 280 12 626 26 317 42 256
OTHER 17 1 52 2 24 3 18
PEOLC 27 1 52 5 61 13 79
PREV 365 6 313 20 244 47 286
SXQOL 689 5 261 49 597 98 597
Total 2341 31 1617 143 1742 325 1978

26-APR-2025 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 733 10 522 77 937 159 968
CCD 520 1 52 5 61 16 97
ERLYTX 78 3 157 12 146 21 128
GI 217 2 104 22 268 34 207
GU 525 10 522 48 584 89 542
LEUK 520 7 365 41 499 119 724
LUNG 857 14 730 38 463 62 377
LYMPH 294 10 522 32 390 73 444
MELAN 434 3 157 31 377 69 420
MMYEL 316 1 52 16 195 29 177
MULT 20 0 0 0 0 0 0
OTHER 63 1 52 3 37 6 37
PEOLC 27 1 52 5 61 13 79
PREV 373 6 313 20 244 49 298
SXQOL 696 6 313 50 609 99 603
Total 5673 75 3913 400 4871 838 5101

26-APR-2025 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 436 6 313 52 633 100 609
ERLYTX 41 2 104 8 97 11 67
GI 174 2 104 17 207 26 158
GU 454 7 365 41 499 78 475
LEUK 57 0 0 2 24 8 49
LUNG 354 1 52 8 97 13 79
LYMPH 195 6 313 17 207 44 268
MELAN 249 1 52 15 183 40 244
MMYEL 200 1 52 10 122 19 116
MULT 13 0 0 0 0 0 0
OTHER 46 0 0 1 12 3 18
PREV 8 0 0 0 0 2 12
SXQOL 7 1 52 1 12 1 6
Total 2234 27 1407 172 2093 345 2101

26-APR-2025 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
CCD 437 0 0 4 49 15 91
ERLYTX 5 0 0 0 0 2 12
GU 4 0 0 0 0 0 0
LEUK 192 3 157 20 244 41 250
LUNG 147 3 157 15 183 23 140
OTHER 17 1 52 2 24 3 18
PEOLC 18 1 52 3 37 7 43
PREV 345 6 313 20 244 47 286
SXQOL 465 5 261 28 341 59 359
Total 1630 19 992 92 1122 197 1199

26-APR-2025 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 597 12 626 69 840 142 864
CCD 472 2 104 12 146 27 164
ERLYTX 46 2 104 8 97 13 79
GI 178 3 157 17 207 27 164
GU 471 7 365 39 475 79 481
LEUK 249 3 157 22 268 49 298
LUNG 502 4 209 24 292 37 225
LYMPH 195 6 313 17 207 44 268
MELAN 249 1 52 15 183 40 244
MMYEL 198 1 52 7 85 14 85
MULT 11 0 0 0 0 0 0
OTHER 172 1 52 16 195 40 244
PEOLC 31 2 104 7 85 14 85
PREV 353 6 313 20 244 49 298
SURV 3 0 0 1 12 2 12
SXQOL 472 6 313 29 353 60 365
Total 4199 56 2921 303 3689 637 3876

26-APR-2025 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 646 9 470 67 816 136 828
ERLYTX 71 3 157 12 146 18 110
GI 110 2 104 12 146 20 122
GU 243 4 209 27 329 52 317
LEUK 61 2 104 4 49 11 67
LUNG 549 2 104 11 134 16 97
LYMPH 219 10 522 28 341 58 353
MELAN 5 0 0 0 0 0 0
MMYEL 302 1 52 14 170 27 164
MULT 20 0 0 0 0 0 0
Total 2226 33 1722 175 2131 338 2058

26-APR-2025 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

Inst. Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
Member 2010 22 1148 145 1765 310 1887
AFFIL 212 6 313 17 207 31 189
CCOP/NCORP 1642 18 939 102 1242 201 1224
Non-SWOG 1806 26 1357 133 1619 293 1784
Total 5670 72 3757 397 4833 835 5084

26-APR-2025 6:11

STUDIES OPENED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
LEUK MM1OA-S03 AML, Newly Dx, Ven+ASTX727 vs Ven+ASTX727+Ena 1 Y 01-APR-25

26-APR-2025 6:11

STUDIES CLOSED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
LEUK A042001 B-Cell ALL, Inotuzunab+chemo v Standard chemo 0 E 27-MAR-25
LEUK A042001 B-Cell ALL, Inotuzunab+chemo v Standard chemo 1 E 27-MAR-25
GI EA2197 Gal, Rando Perioperative TX 1 E 18-APR-25
BREAST S2007 Breast, Brain Mets, Sacituzumab Govitecan 1 N 07-APR-25
LYMPH S1918 DLBCL, Adv, Age 75+, CC-486 +/- R-miniCHOP 1 T 01-APR-25

26-APR-2025 6:11

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

ADMIN STUDYID STNAME REGTYPE Registrations
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 1 15
LUNG LUNGMAP NSCLC, Adv, Master 1 12
BREAST S2212 Breast, TNBC, Neoadj Chemo + Pembro 1 6
GU EA8212 Blad, NMIBC, BRIDGE 1 5
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 1 5
PREV NRGCC005 Colon,Non-AdvancedAdenomas,Colonoscopy5v10yrs 1 5
LYMPH S2114 NHL, Rel/Ref, CD19 CAR-T +/- Consolidation 1 5
LYMPH S2308 FL, LTB, Mosunetuzumab vs Rituximab 1 5
CCD S1703 Met Breast, STM-monitoring v Usual Care 1 3
GU S1931 RENAL, Stg IV, IO + Nephrectomy. vs IO Only 2 3
ERLYTX S2012 Extrapulm NEC, Stg IV, Combo Chemo +/- Atezo 1 3
SXQOL S2013 I-CHECKIT: ICI toxicity risk prediction study 1 3
MELAN S2015 MELAN, Stg I-II, 1cm v 2cm excision margins 1 3
LYMPH S2114 NHL, Rel/Ref, CD19 CAR-T +/- Consolidation 2 3
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 2 3